ATANASOVA, Velina S, Crhistian de Jesus CARDONA, Václav HEJRET, Andreas TIEFENBACHER, Theresia MAIR, Loan TRAN, Janette PFNEISSL, Kristina DRAGANIC, Carina BINDER, Julijan KABILJO, Janik CLEMENT, Katharina WOERAN, Barbara NEUDERT, Sabrina WOHLHAUPTER, Astrid HAASE, Sandra DOMAZET, Markus HENGSTSCHLAEGER, Markus MITTERHAUSER, Leonhard MUELLAUER, Boris TICHÝ, Michael BERGMANN, Gabriele SCHWEIKERT, Markus HARTL, Helmut DOLZNIG a Gerda EGGER. Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. UNITED STATES: ELSEVIER INC, 2023, roč. 15, č. 6, s. 1391-1419. ISSN 2352-345X. Dostupné z: https://dx.doi.org/10.1016/j.jcmgh.2023.02.014.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model
Autoři ATANASOVA, Velina S, Crhistian de Jesus CARDONA, Václav HEJRET (203 Česká republika, domácí), Andreas TIEFENBACHER, Theresia MAIR, Loan TRAN, Janette PFNEISSL, Kristina DRAGANIC, Carina BINDER, Julijan KABILJO, Janik CLEMENT, Katharina WOERAN, Barbara NEUDERT, Sabrina WOHLHAUPTER, Astrid HAASE, Sandra DOMAZET, Markus HENGSTSCHLAEGER, Markus MITTERHAUSER, Leonhard MUELLAUER, Boris TICHÝ (203 Česká republika, domácí), Michael BERGMANN, Gabriele SCHWEIKERT, Markus HARTL, Helmut DOLZNIG a Gerda EGGER (garant).
Vydání CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, UNITED STATES, ELSEVIER INC, 2023, 2352-345X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30219 Gastroenterology and hepatology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 7.200 v roce 2022
Kód RIV RIV/00216224:14740/23:00133185
Organizační jednotka Středoevropský technologický institut
Doi http://dx.doi.org/10.1016/j.jcmgh.2023.02.014
UT WoS 001030618700001
Klíčová slova anglicky Colorectal Cancer; Fibroblasts; Organoids; targeted therapy
Štítky CF GEN, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Eva Dubská, učo 77638. Změněno: 8. 4. 2024 09:34.
Anotace
BACKGROUND & AIMS: Patient-derived organoid cancer models are generated from epithelial tumor cells and reflect tumor characteristics. However, they lack the complexity of the tumor microenvironment, which is a key driver of tumorigenesis and therapy response. Here, we developed a colorectal cancer organoid model that incorporates matched epithelial cells and stromal fibroblasts. METHODS: Primary fibroblasts and tumor cells were isolated from colorectal cancer specimens. Fibroblasts were character-ized for their proteome, secretome, and gene expression sig-natures. Fibroblast/organoid co-cultures were analyzed by immunohistochemistry and compared with their tissue of origin, as well as on gene expression levels compared with standard organoid models. Bioinformatics deconvolution was used to calculate cellular proportions of cell subsets in orga-noids based on single-cell RNA sequencing data. RESULTS: Normal primary fibroblasts, isolated from tumor adjacent tissue, and cancer associated fibroblasts retained their molecular characteristics in vitro, including higher motility of cancer associated compared with normal fibroblasts. Impor-tantly, both cancer-associated fibroblasts and normal fibro-blasts supported cancer cell proliferation in 3D co-cultures, without the addition of classical niche factors. Organoids grown together with fibroblasts displayed a larger cellular heteroge-neity of tumor cells compared with mono-cultures and closely resembled the in vivo tumor morphology. Additionally, we observed a mutual crosstalk between tumor cells and fibro-blasts in the co-cultures. This was manifested by considerably deregulated pathways such as cell-cell communication and extracellular matrix remodeling in the organoids. Thrombospondin-1 was identified as a critical factor for fibro-blast invasiveness. CONCLUSION: We developed a physiological tumor/stroma model, which will be vital as a personalized tumor model to study disease mechanisms and therapy response in colorectal cancer. (Cell Mol Gastroenterol Hepatol 2023;15:1391-1419; https://doi.org/10.1016/j.jcmgh.2023.02.014)
Návaznosti
90267, velká výzkumná infrastrukturaNázev: NCMG III
VytisknoutZobrazeno: 7. 6. 2024 16:53